Uses of anti-Müllerian hormone (AMH) measurement before and after cancer treatment in women

Maturitas

Volumn 80, Issue 3, 2015, Pages 245-250

  Dunlop, Cheryl E ^a   Anderson, Richard A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Anti M llerian hormone; Cancer; Chemotherapy; Ovarian reserve; Premature ovarian insufficiency

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; MUELLERIAN INHIBITING FACTOR;

BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER THERAPY; FERTILITY PRESERVATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MENSTRUATION; OVARIAN RESERVE; OVARY FUNCTION; PATIENT COUNSELING; PREMATURE OVARIAN FAILURE; REPRODUCTIVE HEALTH; REVIEW; BLOOD; BREAST NEOPLASMS; FEMALE; WOMEN'S HEALTH;

ANTI-MULLERIAN HORMONE; BIOMARKERS; BREAST NEOPLASMS; FEMALE; HUMANS; OVARIAN RESERVE; WOMEN'S HEALTH;

EID: 84922977128     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.12.005     Document Type: Review

References (57)

1. J.K. Findlay, K.J. Hutt, M. Hickey, and R.A. Anderson What is the 'ovarian reserve' Fertil Steril 2014 10.1016/j.fertnstert.2014.10.037 pii:S0015-0282(14)02297-3, [Epub ahead of print]
2. D. Dewailly, C.Y. Andersen, and A. Balen The physiology and clinical utility of anti-Mullerian hormone in women Hum Reprod Update 20 2014 370 385
3. L.A. Kondapalli, K.E. Dillon, and M.D. Sammel Quality of life in female cancer survivors: is it related to ovarian reserve? Qual Life Res 23 Mar (2) 2014 585 592
4. M. De Vos, J. Smitz, and T.K. Woodruff Fertility preservation in women with cancer Lancet 384 Oct (9950) 2014 1302 1310
5. D.M. Green, T. Kawashima, and M. Stovall Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study J Clin Oncol 27 2009 2677 2685
6. S.E. Barton, NajitaJS, and E.S. Ginsburgh Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort Lancet Oncol 14 2013 873 881
7. J.M. Letourneau, E.E. Ebbel, and P.P. Katz Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer Cancer 118 Apr (7) 2012 1933 1939
8. J.A. Petrek, M.J. Naughton, and L.D. Case Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study J Clin Oncol 24 2006 1045 1051
9. S. Morgan, R.A. Anderson, C. Gourley, W.H. Wallace, and N. Spears How do chemotherapeutic agents damage the ovary? Hum Reprod Update 18 Sep-Oct (5) 2012 525 535
10. E.C. Roti Roti, S.K. Leisman, D.H. Abbott, and S.M. Salih Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent PLoS One 7 2012 e42293
11. S. Morgan, F. Lopes, C. Gourley, R.A. Anderson, and N. Spears Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin PLoS One 8 7 2013 e70117
12. R.A. Anderson, A.P. Themmen, A. Al-Qahtani, N.P. Groome, and D.A. Cameron The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer Hum Reprod 21 10 2006 2583 2592
13. S. Lie Fong, J.S. Laven, and F.G. Hakvoort-Cammel Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone Hum Reprod 24 4 2009 982 990
14. H. Mörse, M. Elfving, A. Lindgren, P. Wölner-Hanssen, C.Y. Andersen, and I. ∅ra Acute onset of ovarian dysfunction in young females after start of cancer treatment Pediatr Blood Cancer 60 4 2013 676 681
15. A.J. Lunsford, K. Whelan, K. McCormick, and J.F. McLaren Anti-Müllerian hormone as a measure of reproductive function in female childhood cancer survivors Fertil Steril 101 1 2014 227 231
16. W.H.B. Wallace, A.B. Thomson, and T.W. Kelsey The radiosensitivity of the human oocyte Hum Reprod 18 2003 117 121
17. J.G. Franco Jr., J.B. Oliveira, C.G. Petersen, A.L. Mauri, R. Baruffi, and M. Cavagna Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility Med Hypotheses 78 4 2012 442 445
18. T.W. Kelsey, P. Wright, S.M. Nelson, R.A. Anderson, and W.H. Wallace A validated model of serum anti-Müllerian hormone from conception to menopause PLoS One 6 2011 e22024
19. J.V. Jeppesen, R.A. Anderson, and T.W. Kelsey Which follicles make the most anti-Müllerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection Mol Hum Reprod 19 8 2013 519 527
20. J.G. Bentzen, J.L. Forman, T.H. Johannsen, A. Pinborg, E.C. Larsen, and A.N. Andersen Ovarian antral follicle subclasses and anti-Müllerian hormone during normal reproductive aging J Clin Endocrinol Metab 98 2013 1602 1611
21. A.L. Durlinger, P. Kramer, and B. Karels Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary Endocrinology 140 1999 5789 5796
22. A.L. Durlinger, M.J. Gruijters, and P. Kramer Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary Endocrinology 142 2001 4891 4899
23. K.R. Hansen, G.M. Hodnett, N. Knowlton, and L.B. Craig Correlation of ovarian reserve tests with histologically determined primordial follicle number Fertil Steril 95 2011 170 175
24. J.G. Bentzen, J.L. Forman, and A. Pinborg Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception Reprod Biomed Online 25 2012 612 619
25. S. Lie Fong, P.J. Lugtenburg, and I. Schipper Anti-Müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies Hum Reprod 23 3 2008 674 678
26. B. Lawrenz, T. Fehm, and M. von Wolff Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma - evaluation by using anti-Müllerian hormone and retrieved oocytes Fertil Steril 98 2012 141 144
27. H.I. Su, S.W. Flatt, L. Natarajan, A. DeMichele, and A.Z. Steiner Impact of breast cancer on anti-Müllerian hormone levels in young women Breast Cancer Res Treat 137 Jan (2) 2013 571 577
28. W. van Dorp, M.M. van den Heuvel-Eibrink, and A.C. de Vries Decreased serum anti-Müllerian hormone levels in girls with newly diagnosed cancer Hum Reprod 29 2014 337 342
29. S. Titus, F. Li, and R. Stobezki Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans Sci Transl Med 5 Feb (172) 2013 172ra21
30. S.L. Broer, M.J. Eijkemans, and G.J. Scheffer Anti-Müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women J Clin Endocrinol Metab 96 8 2011 2532 2539
31. E.W. Freeman, M.D. Sammel, H. Lin, and C.R. Gracia Anti-Müllerian hormone as a predictor of time to menopause in late reproductive age women J Clin Endocrinol Metab 97 May (5) 2012 1673 1680
32. F.R. Tehrani, M. Solaymani-Dodaran, M. Tohidi, M.R. Gohari, and F. Azizi Modeling age at menopause using serum concentration of anti-Müllerian hormone J Clin Endocrinol Metab 98 2 2013 729 735
33. J. Van Disseldorp, C.B. Lambalk, and J. Kwee Comparison of inter-and intra-cycle variability of anti-Müllerian hormone and antral follicle counts Hum Reprod 25 1 2010 221 227
34. L.E. Bath, W.H. Wallace, M.P. Shaw, C. Fitzpatrick, and R.A. Anderson Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound Hum Reprod 18 11 2003 2368 2374
35. M.F.H. Brougham, P.M. Crofton, E.J. Johnson, N. Evans, R.A. Anderson, and W.H.B. Wallace Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study J Clin Endocrinol Metab 97 2012 2059 2067
36. R.D. van Beek, M.M. van den Heuvel-Eibrink, and J.S. Laven Anti-Müllerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood J Clin Endocrinol Metab 92 10 2007 3869 3874
37. K. Lutchman Singh, S. Muttukrishna, and R.C. Stein Predictors of ovarian reserve in young women with breast cancer Br J Cancer 96 Jun (12) 2007 1808 1816
38. C. Anders, P.K. Marcom, and B. Peterson A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer Cancer Invest 26 2008 286 295
39. C. Decanter, F. Morschhauser, P. Pigny, C. Lefebvre, C. Gallo, and D. Dewailly Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results Reprod Biomed Online 20 2 2010 280 285
40. B. Yu, N. Douglas, and M.J. Ferin Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy Cancer 116 2010 2099 2105
41. M. Rosendahl, C.Y. Andersen, N. la Cour Freiesleben, A. Juul, K. Løssl, and A.N. Andersen Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age Fertil Steril 94 2010 156 166
42. R.A. Anderson, and D.A. Cameron Pretreatment serum anti-Müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer J Clin Endocrinol Metab 96 2011 1336 1343
43. K.E. Dillon, M.D. Sammel, and M. Prewitt Pretreatment anti-Müllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy Fertil Steril 99 2013 477 483
44. R.A. Anderson, M. Rosendahl, T.W. Kelsey, and D.A. Cameron Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer Eur J Cancer 49 2013 3404 3411
45. N.L. Henry, R. Xia, A.F. Schott, D. McConnell, M. Banerjee, and D.F. Hayes Prediction of postchemotherapy ovarian function using markers of ovarian reserve Oncologist 19 1 2014 68 74
46. J. Chai, A.F. Howie, D.A. Cameron, and R.A. Anderson A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer Eur J Cancer 50 Sep (14) 2014 2367 2374
47. M. Dowsett, J. Cuzick, and J. Ingle Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen J Clin Oncol 28 Jan 20 (3) 2010 509 518
48. F.Y. De Vos, H.W. van Laarhoven, and J.S. Laven Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guideline Crit Rev Oncol Hematol 84 Nov (2) 2012 252 260
49. C. Davies, H. Pan, and J. Godwin Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Lancet 381 Mar (9869) 2013 805 816
50. H.I. Su, K. Maas, P. Sluss, R.J. Chang, J.E. Hall, and H. Joffe The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women J Clin Endocrinol Metab 98 2013 E1961 E1966
51. K.J. Ruddy, A. O'Neill, and K.D. Miller Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103 Breast Cancer Res Treat 144 Apr (3) 2014 591 597
52. H.C. Su, C. Haunschild, and K. Chung Prechemotherapy anti-Müllerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients Cancer Jul 31 2014 10.1002/cncr.28942 [Epub ahead of print]
53. W.H. Wallace, H.O. Critchley, and R.A. Anderson Optimizing reproductive outcome in children and young people with cancer J Clin Oncol 30 2012 3 5
54. A.H. Partridge, K.J. Ruddy, and S. Gelber Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer Fertil Steril 94 Jul (2) 2010 638 644
55. S. Iliodromitri, R.A. Anderson, and S.M. Nelson Technical and performance characteristics of anti-Müllerian hormone (AMH) and antral follicle count (AFC) as biomarkers of ovarian response Hum Reprod Update 2014 pii:dmu062, [Epub ahead of print]
56. S. Iliodromiti, T.W. Kelsey, O. Wu, R.A. Anderson, and S.M. Nelson The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature Hum Reprod Update 20 Jul-Aug (4) 2014 560 570
57. S.M. Nelson, S. Iliodromiti, R. Fleming, R. Anderson, A. McConnachie, and C.M. Messow Reference range for the anti-Müllerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram Fertil Steril 101 2014 523 529